Ceteris Holding B.V., Amsterdam, Olanda, Succursale Di Lugano – Trademark Portfolio

Entity Type: 03

Ceteris Holding B.V., Amsterdam, Olanda, Succursale Di Lugano holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. The owner is based in Lugano.

Via Serafino Balestra 27

Lugano 6900 , CH

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Ceteris Holding B.V., Amsterdam, Olanda, Succursale Di Lugano's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Ceteris Holding B.V., Amsterdam, Olanda, Succursale Di Lugano have?

Ceteris Holding B.V., Amsterdam, Olanda, Succursale Di Lugano has 2 U.S. trademarks filed with the USPTO.

What trademark classes does Ceteris Holding B.V., Amsterdam, Olanda, Succursale Di Lugano file in?

Ceteris Holding B.V., Amsterdam, Olanda, Succursale Di Lugano files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Ceteris Holding B.V., Amsterdam, Olanda, Succursale Di Lugano's trademark registration success rate?

Ceteris Holding B.V., Amsterdam, Olanda, Succursale Di Lugano has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.